Compounds > 21-fluoro-16-ethyl-19-norprogesterone
Page last updated: 2024-09-04

21-fluoro-16-ethyl-19-norprogesterone and Hormone-Dependent Neoplasms

21-fluoro-16-ethyl-19-norprogesterone has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Goeij, CJ; de Groot, TJ; Elsinga, PH; Paans, AM; Sluyser, M; Vaalburg, W; Verhagen, A1

Other Studies

1 other study(ies) available for 21-fluoro-16-ethyl-19-norprogesterone and Hormone-Dependent Neoplasms

ArticleYear
A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography.
    Cancer research, 1991, Apr-01, Volume: 51, Issue:7

    Topics: Animals; Female; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Norprogesterones; Rats; Receptors, Estrogen; Receptors, Progesterone; Tomography, Emission-Computed; Uterus

1991